In the Musk v. Altman trial, OpenAI CEO Sam Altman testified that Elon Musk abandoned the nonprofit mission of OpenAI rather than being betrayed by Altman. Musk alleges Altman and others broke promises by converting OpenAI into a for-profit entity, misusing Musk's $38 million donation. Altman countered that Musk sought control and left the company amid funding disputes, with OpenAI's for-profit arm now valued at over $850 billion. The trial highlights tensions over OpenAI's corporate structure and mission, with closing arguments scheduled soon and the judge making the final decision.
Cerebras Systems, an AI chip maker based in Sunnyvale, California, is set to go public on Nasdaq under the ticker CBRS on May 14, 2026, marking the first IPO from TSG Invest's Venture 50 Index. The company raised its IPO price range to $150-$160 per ...
Cerebras Systems, an AI chip maker known for its wafer-scale engine technology, is set to debut on Nasdaq under ticker CBRS, marking the first IPO from TSG Invest's Venture 50 Index. The company raised its IPO price range to $150-$160 per share due t...
Techstars has formed a strategic partnership with fintech platform Xendoo and accounting software Xero to offer startups a comprehensive financial operations solution. This collaboration aims to help early-stage companies maintain better financial vi...
Sapu Nano and Oncotelic have dosed the first patient in a Phase 1b clinical trial of Sapu003, an intravenous formulation of everolimus designed to treat advanced mTOR-sensitive solid tumors such as HR+/HER2- breast cancer and renal cell carcinoma. Th...
The Gabelli Utility Trust Board approved monthly cash distributions of $0.05 per share for July, August, and September 2026, maintaining its fixed monthly payout policy. The Fund's shares currently trade at a premium to net asset value, which the Boa...
